These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9151932)

  • 1. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
    Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553.
    Millan MJ; Girardon S; Bervoets K
    Neuropharmacology; 1997; 36(4-5):743-5. PubMed ID: 9225301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
    Upton N; Stean T; Middlemiss D; Blackburn T; Kennett G
    Eur J Pharmacol; 1998 Oct; 359(1):33-40. PubMed ID: 9831290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
    Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
    Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
    Chagraoui A; Protais P; Filloux T; Mocaër E
    Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
    De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
    J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
    Hewitt KN; Lee MD; Dourish CT; Clifton PG
    Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
    Millan MJ; Dekeyne A; Gobert A
    Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
    Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
    Millan MJ; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors.
    Hajos M; Hoffmann WE; Weaver RJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):605-15. PubMed ID: 12734389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.